Analysis of death receptor 5 and caspase-8 expression in primary and metastatic head and neck squamous cell carcinoma and their prognostic impact - Wikidata - wikimedia - TriplyDB

Analysis of death receptor 5 and caspase-8 expression in primary and metastatic head and neck squamous cell carcinoma and their prognostic impact

Analysis of death receptor 5 and caspase-8 expression in primary and metastatic head and neck squamous cell carcinoma and their prognostic impact

http://www.wikidata.org/entity/Q34068822

about

TNFα cooperates with IFN-γ to repress Bcl-xL expression to sensitize metastatic colon carcinoma cells to TRAIL-mediated apoptosis.Death receptor 5 expression is inversely correlated with prostate cancer progression.Understanding the Role of the Death Receptor 5/FADD/caspase-8 Death Signaling in Cancer Metastasis Drozitumab, a human antibody to death receptor 5, has potent antitumor activity against rhabdomyosarcoma with the expression of caspase-8 predictive of response.TRAIL-R2 promotes skeletal metastasis in a breast cancer xenograft mouse model.Suppression of death receptor 5 enhances cancer cell invasion and metastasis through activation of caspase-8/TRAF2-mediated signaling.The Deubiquitinase Inhibitor PR-619 Sensitizes Normal Human Fibroblasts to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-mediated Cell Death.Prognostic impact of Fas-associated death domain, a key component in death receptor signaling, is dependent on the presence of lymph node metastasis in head and neck squamous cell carcinoma Targeted delivery of tumor necrosis factor-related apoptosis-inducing ligand to keratinocytes with a pemphigus mAb.Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development.Fas expression is downregulated in gastric cancer.Compartmentalization of TNF-related apoptosis-inducing ligand (TRAIL) death receptor functions: emerging role of nuclear TRAIL-R2.Journey of TRAIL from Bench to Bedside and its Potential Role in Immuno-Oncology.Epigenetic and expression analysis of TRAIL-R2 and BCL2: on the TRAIL to knowledge of apoptosis in ovarian tumors.Prognostic significance of TRAIL signalling molecules in cervical squamous cell carcinoma.FADD the bad in head and neck cancer.DR5 suppression induces sphingosine-1-phosphate-dependent TRAF2 polyubiquitination, leading to activation of JNK/AP-1 and promotion of cancer cell invasion.TRAIL and TRAIL receptors in patients with laryngeal cancer.Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment.

P2860

Q33802588-4BACD782-96CB-4A8C-B58B-D6FA5CD1FE6C Q34426868-24F62DB9-6E18-4494-BE36-B5BD7F6DF22B Q34731599-C3581FA4-B131-4604-9F56-63473ACEDF93 Q34988055-EB10B54D-841A-4C6A-A7A8-A608DFDFADA0 Q35832412-2D1DB296-C67A-43AC-B798-DBC0413E6689 Q36562365-88DE4FF6-9CE9-4F90-A0C5-EBB6AE7AE028 Q36674724-0171BA9E-69FF-4CE1-98A0-B82E4A66E3FA Q36887771-B72A2AF6-339E-410F-9921-31A4DA2BE642 Q36927030-8B90BEAD-A865-48A8-ABD0-58DFF657B2EA Q37295309-F0BCDAAC-BB2E-468B-A280-88DB9EBB6F77 Q37720085-BBD6213E-090D-4A92-8627-82A768BC666E Q38244150-E67F02A5-07A6-4151-94CF-FE392629FAD8 Q38557486-C7074AF0-AB89-4DBD-A73B-478FA572D9B1 Q39066974-C22D85DE-4ADA-42FE-B7B2-6433527D5A10 Q41502828-2BF7A2F9-334B-468B-BE7F-9FA87F3B18E5 Q41905193-630A05C2-CE91-4A96-950C-9CC35217D927 Q42283261-F8FC2112-D843-4D14-9C8E-02642739D743 Q45874298-8FF9AA83-7CA6-4821-842B-B3DE5AB62D2C Q52658085-927DF7FD-4FCA-47A0-9C89-04B74ECF4C09

P2860

Analysis of death receptor 5 and caspase-8 expression in primary and metastatic head and neck squamous cell carcinoma and their prognostic impact

http://www.wikidata.org/entity/Q34068822

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Analysis of death receptor 5 a ...... ma and their prognostic impact

@ast

Analysis of death receptor 5 a ...... ma and their prognostic impact

@en

Analysis of death receptor 5 a ...... ma and their prognostic impact

@nl

type

label

Analysis of death receptor 5 a ...... ma and their prognostic impact

@ast

Analysis of death receptor 5 a ...... ma and their prognostic impact

@en

Analysis of death receptor 5 a ...... ma and their prognostic impact

@nl

prefLabel

Analysis of death receptor 5 a ...... ma and their prognostic impact

@ast

Analysis of death receptor 5 a ...... ma and their prognostic impact

@en

Analysis of death receptor 5 a ...... ma and their prognostic impact

@nl

P1433

Q34068822-C61D33E7-FF86-4F87-91BB-EB90AF8F40C3

P1476

Q34068822-207270B3-5FEF-401A-ABD5-E4358C2D24B0

P2093

Q34068822-3523DEBD-80E5-49B6-A539-B28967F31319

Q34068822-4152B80E-EB98-4FE1-ABC7-B121D1A8C68E

Q34068822-4201FF8D-341A-4556-8875-0F7AD31D92A0

Q34068822-82E1B5B0-7D9C-4DEA-970D-59403B0A84CF

Q34068822-B2A666D5-6717-4D54-A14E-43B7B17E1FD3

Q34068822-CA55EB56-4F13-40F1-8D88-06C02AD8EE8F

Q34068822-D37945A7-CC2E-4E3F-A71C-E105E3A77D1D

Q34068822-E930CEE8-7648-4A21-98A7-91F8ECC79DBF

Q34068822-ED63B0A4-CD49-4FE8-B196-10EE6E17D721

P2860

Q34068822-00A58886-BADB-4C16-864F-F559325C4E7A

Q34068822-02526E44-5026-41CE-A1BB-5C96940377B9

Q34068822-0283FF58-4DF8-4F97-8850-5F2549D7696B

Q34068822-10B6DBF1-31A1-4F41-9B42-FA8FCC1100A5

Q34068822-1A9097EA-A429-435B-B675-75BF3E4C36C0

Q34068822-1A9E81AA-C796-4454-B006-E38149701102

Q34068822-2323F06D-33E8-4883-8D41-41AF8514782E

Q34068822-2543EA84-2145-4E1D-9B5B-17F7299BA466

Q34068822-257970FB-4822-480E-B807-08D826C9E19F

Q34068822-290414DA-8A38-4510-94B9-423508EF4369

P304

Q34068822-0FB1D41F-0BE0-4539-B8A7-CBE1F14BB66F

P31

Q34068822-799A2305-1F2E-43A0-9BCF-EF6AE855EE32

P356

Q34068822-F4CFCD9E-01AF-4669-A120-11ABADD03F0D

P407

Q34068822-9BC73017-459C-4C1C-B327-0B3A46E578A5

P433

Q34068822-D1C16CA9-FFFF-4554-A8B7-A33E24AC361C

P478

Q34068822-9BD2F2A1-EBD0-44B3-8910-7855B267169A

P577

Q34068822-16A6D43D-3AF1-41C6-861A-777BE68D2CC1

P5875

Q34068822-C74787C5-6164-4772-8A03-75AF3DF01BB8

P698

Q34068822-6C99B189-6452-4CB6-B2C1-728D1E88F86F

P921

Q34068822-33893785-AF19-4637-A101-B0DC434CEBDB

P932

Q34068822-4A657D02-A8C8-4F4A-9138-B8A99CBF243D

P356

JOURNAL.PONE.0012178

P1433

P1476

Analysis of death receptor 5 a ...... ma and their prognostic impact

@en

P2093

Dong M Shin

http://www.w3.org/2001/XMLSchema#string

Fadlo R Khuri

http://www.w3.org/2001/XMLSchema#string

Georgia Z Chen

http://www.w3.org/2001/XMLSchema#string

Heath A Elrod

http://www.w3.org/2001/XMLSchema#string

Lin Pan

http://www.w3.org/2001/XMLSchema#string

Mourad Tighiouart

http://www.w3.org/2001/XMLSchema#string

Shi-Yong Sun

http://www.w3.org/2001/XMLSchema#string

Songqing Fan

http://www.w3.org/2001/XMLSchema#string

Susan Muller

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2002

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy

Cancer statistics, 2009

The biochemistry of apoptosis

TNF-related apoptosis inducing ligand (TRAIL) and its receptors in tumor surveillance and cancer therapy.

Cigarette smoke condensate increases cathepsin-mediated invasiveness of oral carcinoma cells

State-of-the-art management of locally advanced head and neck cancer.

TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development

CD95L/FasL and TRAIL in tumour surveillance and cancer therapy.

Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion.

P304

e12178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0012178

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46108191

http://www.w3.org/2001/XMLSchema#string

P698

20808443

http://www.w3.org/2001/XMLSchema#string

P921

head and neck squamous cell carcinoma

P932

2922336

http://www.w3.org/2001/XMLSchema#string